AbbVie Inc. — Director's Dealing 2024

Jul 2, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-06-30

Reporting Person: RAPP EDWARD J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-30	Stock Equivalent Units	$171.52	A	225	Acquired		Common Stock (225)	Direct

Footnotes

F1: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.